Deschloroclotizolam is a thienotriazolodiazepine derivative which was first synthesised in 1979, but was never marketed. It has subsequently been sold as a designer drug, first being definitively identified in 2017.
This product is intended for laboratory research purposes only and are not to be used for any other purposes.
Deschloroclotizolam is for research use – Not for human or veterinary diagnostic or therapeutic use. It is the responsibility of the purchaser to determine suitability for other applications.
There are no reviews yet.